Two Ebola Vaccines Spur Lasting Immune Response

WEDNESDAY, Oct. 11, 2017 — Two experimental vaccines against the deadly Ebola virus are able to trigger an immune response that lasts for at least a year, a new clinical trial has found.
Experts said the results give more support to one of the…
Source: Topamax